Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aprepitant crossover study of substance P release during peritoneal dialysis
2012-005063-28Phase 2Completed
- Sponsor
- University of Gothenburg
- Start
- Nov 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of aprepitant in end-stage kidney disease (ESKD), sponsored by University of Gothenburg. Started Nov 2012; status: completed.
02
Drugs
aprepitant
03
Conditions
end-stage kidney disease (ESKD)
Beyond the preview
Go deeper on 2012-005063-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-005063-28.